Development of replication-competent viral vectors for HIV vaccine delivery

Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins

(2013) A W Hudacek et al.   CANCER GENE THERAPY

Trivalent Live Attenuated Influenza-Simian Immunodeficiency Virus Vaccines: Efficacy and Evolution of Cytotoxic T Lymphocyte Escape in Macaques

(2013) J. C. Reece et al.   JOURNAL OF VIROLOGY

Mucosal Priming with a Replicating-Vaccinia Virus-Based Vaccine Elicits Protective Immunity to Simian Immunodeficiency Virus Challenge in Rhesus Monkeys

(2013) C. Sun et al.   JOURNAL OF VIROLOGY

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

(2013) Marc Gurwith et al.   LANCET INFECTIOUS DISEASES

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques

(2013) Clarisse Lorin et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Immunogenicity of Seven New Recombinant Yellow Fever Viruses 17D Expressing Fragments of SIVmac239 Gag, Nef, and Vif in Indian Rhesus Macaques

(2013) Mauricio A. Martins et al.   PLoS One

HIV-1 p24gag Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice

(2013) Viraj Kulkarni et al.   PLoS One

Genomic Sequence and Virulence of Clonal Isolates of Vaccinia Virus Tiantan, the Chinese Smallpox Vaccine Strain

(2013) Qicheng Zhang et al.   PLoS One

Evaluation of a replication-competent VSV-SIV vaccine candidate

(2013) CK Jurgens et al.   Retrovirology

History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system

(2013) Charles H. Hoke et al.   VACCINE

Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome

(2012) Scott A. Handley et al.   CELL

Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Vectors Efficiently Prime SIV-Specific Systemic and Mucosal Immune Responses by Targeting Myeloid Dendritic Cells and Persisting in Rectal Macrophages, Regardless of Immunization Route

(2012) L. Jean Patterson et al.   Clinical and Vaccine Immunology

Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

(2012) Geraldine A. O’Hara et al.   JOURNAL OF INFECTIOUS DISEASES

Reevaluation of the Coding Potential and Proteomic Analysis of the BAC-Derived Rhesus Cytomegalovirus Strain 68-1

(2012) D. Malouli et al.   JOURNAL OF VIROLOGY

Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIVmac251Challenge

(2012) Peng Xiao et al.   JOURNAL OF VIROLOGY

Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Human Varicella-Zoster Virus

(2012) D. O. Willer et al.   JOURNAL OF VIROLOGY

Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines

(2012) Yoshinori Fukazawa et al.   NATURE MEDICINE

Comparison on Virulence and Immunogenicity of Two Recombinant Vaccinia Vaccines, Tian Tan and Guang9 Strains, Expressing the HIV-1 Envelope Gene

(2012) Rong Zhu et al.   PLoS One

Elicitation of Both Anti HIV-1 Env Humoral and Cellular Immunities by Replicating Vaccinia Prime Sendai Virus Boost Regimen and Boosting by CD40Lm

(2012) Xianfeng Zhang et al.   PLoS One

Immunogenicity of a Recombinant Measles-HIV-1 Clade B Candidate Vaccine

(2012) Richard Stebbings et al.   PLoS One

Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics

(2012) W.-H. W. Lin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants

(2012) Rui Gu et al.   VACCINE

Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers

(2012) Konstantin Virnik et al.   VACCINE

Broadly neutralizing antibodies against HIV-1: Templates for a vaccine

(2012) Marit J. van Gils et al.   VIROLOGY

New Paradigms for HIV/AIDS Vaccine Development

(2011) Louis J. Picker et al.   Annual Review of Medicine

New Japanese encephalitis vaccines: alternatives to production in mouse brain

(2011) Scott B Halstead et al.   Expert Review of Vaccines

Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: Implications for AIDS vaccine development using Sendai virus vectors

(2011) Hiroto Hara et al.   Human vaccines & immunotherapeutics

Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany

(2011) Stephan Günther et al.   JOURNAL OF INFECTIOUS DISEASES

Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections

(2011) Thomas W. Geisbert et al.   JOURNAL OF INFECTIOUS DISEASES

Significant Protection against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen

(2011) J. B. Schell et al.   JOURNAL OF VIROLOGY

Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus

(2011) J. P. Bilello et al.   JOURNAL OF VIROLOGY

Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs

(2011) S. K. Khattar et al.   JOURNAL OF VIROLOGY

A Novel Self-Replicating Chimeric Lentivirus-Like Particle

(2011) C. K. Jurgens et al.   JOURNAL OF VIROLOGY

Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis

(2011) Tanner S Miest et al.   MOLECULAR THERAPY

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

(2011) Scott G. Hansen et al.   NATURE

Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors

(2011) Esther D. Quakkelaar et al.   PLoS One

Improved NYVAC-Based Vaccine Vectors

(2011) Karen V. Kibler et al.   PLoS One

Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies

(2011) Chikaya Moriya et al.   VACCINE

Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques

(2011) Marta L. Marthas et al.   VACCINE

A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells

(2011) Thomas Mourez et al.   VIROLOGY

HIV vaccine development at the turn of the 21st century

(2011) Marc P. Girard et al.   Current Opinion in HIV and AIDS

Systems vaccinology

(2011) Helder I. Nakaya et al.   Current Opinion in HIV and AIDS

Early Events in Sexual Transmission of HIV and SIV and Opportunities for Interventions

(2010) Ashley T. Haase   Annual Review of Medicine

Replicating viral vectors as HIV vaccines: Summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference

(2010) J.L. Excler et al.   BIOLOGICALS

Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice

(2010) J. Maamary et al.   JOURNAL OF VIROLOGY

In Vivo Tropism of Attenuated and Pathogenic Measles Virus Expressing Green Fluorescent Protein in Macaques

(2010) R. D. de Vries et al.   JOURNAL OF VIROLOGY

Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques

(2010) M. C. Bonaldo et al.   JOURNAL OF VIROLOGY

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys

(2010) Sampa Santra et al.   NATURE MEDICINE

25 years after HIV discovery: Prospects for cure and vaccine

(2010) Luc Montagnier   VIROLOGY

Poxvirus vector-based HIV vaccines

(2010) Giuseppe Pantaleo et al.   Current Opinion in HIV and AIDS

Prime-Boost Vaccination with Recombinant Mumps Virus and Recombinant Vesicular Stomatitis Virus Vectors Elicits an Enhanced Human Immunodeficiency Virus Type 1 Gag-Specific Cellular Immune Response in Rhesus Macaques

(2009) R. Xu et al.   JOURNAL OF VIROLOGY

Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

(2009) M.-R. Abrahams et al.   JOURNAL OF VIROLOGY

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

(2009) Scott G Hansen et al.   NATURE MEDICINE

Viruses as vaccine vectors for infectious diseases and cancer

(2009) Simon J. Draper et al.   NATURE REVIEWS MICROBIOLOGY

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

(2009) Supachai Rerks-Ngarm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge

(2009) Elizabeth J. Faul et al.   VACCINE

Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge

(2009) John Schell et al.   VACCINE

In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation

(2009) J. Erik Johnson et al.   VACCINE

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE

Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: Attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV

(2009) Koen K.A. Van Rompay et al.   VACCINE

Replicating viral vectors as HIV vaccines

(2008) W.C. Koff et al.   BIOLOGICALS

Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development

(2008) L Jean Patterson et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

(2008) Denis Gaucher et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Optimization of Human Immunodeficiency Virus Gag Expression by Newcastle Disease Virus Vectors for the Induction of Potent Immune Responses

(2008) E. Carnero et al.   JOURNAL OF VIROLOGY

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

(2008) Troy D Querec et al.   NATURE IMMUNOLOGY

Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice

(2008) Maria A. Croyle et al.   PLoS One

Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors

(2008) N. F. Rose et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes

(2008) Kaifan Dai et al.   VACCINE